Cardiac Arrhythmia Monitoring Device Market Report By Type (ECG monitors, Implantable monitors, Holter monitors, Mobile cardiac telematory, Others), Application (Tachycardia, Atrial Tachycardia, Ventricular Tachycardia, Bradycardia, Premature Contraction), End User (Hospitals & Clinics, Diagnostic Centers, Others), Countries and Company Analysis 2024-2032

Buy Now
Excel: 8 Hours
PDF: 24 Hours
Jul 2024

FAQs

The global cardiac arrhythmia monitoring devices market was valued at USD 6.21 Billion in 2023 and is expected to reach USD 11.55 billion by 2032, growing at a CAGR of 7.14% during the forecast period (2024-2032).

Factors driving the market's growth include the increasing prevalence of heart disease, use of telecardiology, the ease of use and portability of cardiac arrhythmia monitoring devices, and the development of smart cardiac monitors.

The market includes various types of devices such as ECG monitors, Implantable monitors, Holter monitors and Mobile cardiac.

These devices are used in Tachycardia, Atrial Tachycardia, Ventricular Tachycardia, Bradycardia and Premature Contraction.

The major key players include Abott Laboratories, GE healthcare, Koninklijke Philips N.V.,, Medtronic PLC, Asahi Kasei Corporation, Boston scientific corporation, iRhythm Technologies and Nihon kohden.